Segment information (Tables)

9 Months Ended

Oct. 01, 2017

The following tables present the Company’s segment results for the three and nine months ended October 1, 2017 and September 25, 2016:



	Three Months Ended				Nine Months Ended
	October 1, 2017		September 25, 2016		October 1, 2017		September 25, 2016
	(Dollars in thousands)				(Dollars in thousands)
Revenue
Vascular North America	$	90,979	$	85,118	$	278,350	$	254,817
Anesthesia North America	50,819		48,670		148,107		143,821
Surgical North America	40,804		41,827		131,464		123,904
EMEA	131,517		121,398		394,212		375,198
Asia	72,387		64,087		185,328		176,434
OEM	48,589		41,418		137,067		115,693
All other	99,608		53,130		276,669		164,227
Consolidated net revenues	$	534,703	$	455,648	$	1,551,197	$	1,354,094



	Three Months Ended						Nine Months Ended
	October 1, 2017			September 25, 2016			October 1, 2017			September 25, 2016
	(Dollars in thousands)						(Dollars in thousands)
Operating profit
Vascular North America	$	25,212		$	21,781		$	75,286		$	63,431
Anesthesia North America	15,684			13,954			49,727			41,181
Surgical North America	13,618			14,050			47,285			39,654
EMEA	24,187			16,576			69,677			61,563
Asia	20,217			18,072			49,619			52,831
OEM	12,256			10,201			31,714			24,605
All other	11,987			3,444			16,953			16,623
Total segment operating profit ⁽¹⁾	123,161			98,078			340,261			299,888
Unallocated expenses ⁽²⁾	(12,807		)	(11,591		)	(58,886		)	(47,463		)
Income from continuing operations before interest, loss on extinguishment of debt and taxes	$	110,354		$	86,487		$	281,375		$	252,425

(1)

Segment operating profit includes segment net revenues from external customers reduced by the segment's standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as net revenues, numbers of employees, and amount of time spent), depending on the category of expense involved.


(2)	Unallocated expenses primarily include manufacturing variances other than fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.